Haemonetics announces Q3 FY2022 results; no figures in filing text

HAEMONETICS CORP

2022-Q3 EPS reported $0.65 revenue$728,194,000

Filing reports Q3 and nine-month results for period ended Jan 1, 2022.
Press release (Exhibit 99.1) is referenced but its content is not provided in the filing text shown.
Specific revenue, EPS, or guidance numbers are absent from the available document.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.